Skip to main content

CORRECTION article

Front. Immunol., 25 September 2024
Sec. Vaccines and Molecular Therapeutics
Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1494940

Corrigendum: Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV

This article is a correction to:

  1. Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV

    1. Read original article
Shi Zou,&#x;Shi Zou1,2†Wei Guo,&#x;Wei Guo3,4†Songjie Wu,&#x;Songjie Wu2,5†Fangzhao MingFangzhao Ming6Yuting Tan,Yuting Tan1,2Mengmeng Wu,Mengmeng Wu1,2Weiming Tang,*Weiming Tang7,8*Ke Liang,,,*Ke Liang1,2,5,9*
  • 1Department of Infectious Diseases, Zhongyang Hospital of Wuhan University, Wuhan, China
  • 2Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China
  • 3Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, China
  • 4Department of Pathology, School of Basic Medical Sciences, Wuhan University, Wuhan, China
  • 5Department of Nosocomial Infection Management, Zhongnan Hospital of Wuhan University, Wuhan, China
  • 6Wuchang District Center for Disease Control and Prevention, Wuhan, China
  • 7Guangdong Second Provincial General Hospital, Guangdong, China
  • 8The University of North Carolina at Chapel Hill Project-China, Guangzhou, China
  • 9Hubei Engineering Center for Infectious Disease Prevention, Control and Treatment, Wuhan, China

A Corrigendum on
Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV

By Zou S, Guo W, Wu S, Ming F, Tan Y, Wu M, Tang W and Liang K (2022). Front. Immunol. 13:988304. doi: 10.3389/fimmu.2022.988304

In the published article there was an error in affiliation 7. Instead of “Guangdong No. 2 Provincial People’s Hospital, Guangzhou, China”, it should be “Guangdong Second Provincial General Hospital, Guangdong, China”.

In the published article, there was an error in the Funding statement. One of the funding sources was not included (Shenzhen Fundamental Research Program (JCYJ20210324140401004)). The correct Funding statement appears below.

“This work was supported by the National Key Research and Development Program of China (2017YFE0103800), the National Nature Science Foundation of China (81903371), NIMH (R34MH119963), the National Science and Technology Major Project (2018ZX10101-001-001-003), Shenzhen Fundamental Research Program (JCYJ20210324140401004), Special Found on Prevention and Control of New Coronary Pneumonia in Guangdong Universities (2020KZDZX1047), Medical Science and Technology Innovation Platform Support Project of Zhongnan Hospital, Wuhan University (PTXM2020008), the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2020-PT320-004), Science and Technology Innovation Cultivation Fund of Zhongnan Hospital, Wuhan University (cxpy2017043), Medical Science Advancement Program (Basic Medical Sciences) of Wuhan University (TFJC2018004), and Discipline Cultivation Project of Department of Infectious Diseases, Zhongnan Hospital, Wuhan University (ZNXKPY2021027).”

The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: neutralizing antibodies, inactivated COVID-19 vaccine, people living with HIV (PLWH), seroconversion, longitudinal humoral response

Citation: Zou S, Guo W, Wu S, Ming F, Tan Y, Wu M, Tang W and Liang K (2024) Corrigendum: Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV. Front. Immunol. 15:1494940. doi: 10.3389/fimmu.2024.1494940

Received: 12 September 2024; Accepted: 12 September 2024;
Published: 25 September 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Zou, Guo, Wu, Ming, Tan, Wu, Tang and Liang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Weiming Tang, V2VpbWluZ190YW5nQG1lZC51bmMuZWR1; Ke Liang, a2VsaWFuZ0B3aHUuZWR1LmNu

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.